[1]JournalofMedicinalChemistry,2005,vol.48,p.8261-8269
[2]Patent:WO2005/7625,2005,A2.Locationinpatent:Page64
[3]Patent:US2005/222408,2005,A1
215874-86-5 | 3-(5-Methylisoxazol-3-yl)-6-[(1-methyl-1H-1,2,3-triazol-4-yl)methoxy][1,2,4]triazolo[3,4-a]phthalazine | AA0033DT | MFCD09832717
1091606-70-0 | (1R,2R)-2-(Diphenylphosphino)-2,3-dihydro-1h-inden-1-amine | AA003BDM | MFCD17013983
37136-84-8 | 1-Bromo-2-(3-bromopropoxy)benzene | AA003CTR | MFCD02030868
2122-63-6 | 4-Amino-3-iodobenzoic acid | AA003KMT | MFCD01660550
470688-18-7 | CHLORODICARBONYL(1-(I-PROPYLAMINO)-2,3,4,5-TETRAPHENYLCYCLOPENTADIENYL)RUTHENIUM (II) | AA003OQN | MFCD04038739
13464-82-9 | Indium(III) sulfate | AA003QX6 | MFCD00149747
61790-20-3 | Rare earth naphthenates | AA003U1G | MFCD31567270
15461-27-5 | ZIRCONYL CHLORIDE HYDRATE | AA003VC2 | MFCD06252233
802-31-3 | Prosta-5,13,17-trien-1-oicacid, 11,15-dihydroxy-9-oxo-, (5Z,11a,13E,15S,17Z)- | AA005C75 | MFCD00065758
957120-26-2 | 3-Chloro-5-(methoxycarbonyl)phenylboronic acid | AA006BIF | MFCD09475906